Gene · 94
Papers4,014
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,014
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hereditary haemorrhagic telangiectasia. | Nat Rev Dis Primers | 2025 | 39788978 | PubTator, text mining | PubMed |
| Systemic brain dissemination of glioblastoma requires transdifferentiation into endothelial-like cells via TGF-β-ALK1-Smad1/5 signaling. | Neoplasia | 2025 | 39724753 | PubTator, text mining | PubMed |
| Protein signatures associated with loneliness and social isolation: Plasma proteome analyses in the English Longitudinal Study of Ageing, with causal evidence from Mendelian randomization. | Brain Behav Immun | 2025 | 39586554 | PubTator, text mining | PubMed |
| Multisystem ALK-Positive Histiocytosis With DCTN1::ALK Fusion in an Adult, Responsive to Alectinib: Case Report and Literature Review. | J Cutan Pathol | 2025 | 39403984 | PubTator, text mining | PubMed |
Hereditary Hemorrhagic Telangiectasia with Recurrent Epistaxis, Telangiectasia, Hepatic Arteriovenous Malformation, and a Poorly Developed Middle Cerebral Artery in a Patient with a Novel Mutation in the ACVRL1 Gene. | Intern Med | 2025 | 38960693 | PubTator, text mining | PubMed |
| Cerebrovascular Anomalies in the Fetus. | AJNR Am J Neuroradiol | 2025 | 38866434 | PubTator, text mining | PubMed |
| Efficient and accurate detection of viral sequences at single-cell resolution reveals putative novel viruses perturbing host gene expression. | bioRxiv | 2025 | 38168363 | PubTator, text mining | PubMed |
| Inflammatory myofibroblastic tumour of the larynx: report of a case. | Ear Nose Throat J | 2025 | 35533742 | PubTator, text mining | PubMed |
| SMURF1/2 Are Novel Regulators of WNK1 Stability. | Kinases Phosphatases | 2024 | 40895768 | PubTator, text mining | PubMed |
| Specifications of the ACMG/AMP Variant Curation Guidelines for Hereditary Hemorrhagic Telangiectasia Genes-ENG and ACVRL1. | Hum Mutat | 2024 | 40225928 | PubTator, text mining | PubMed |
| Anaplastic lymphoma kinase1 positive inflammatory myofibroblastic tumor of the urinary bladder: A rare mesenchymal neoplasm with diagnostic and therapeutic implications. | SAGE Open Med Case Rep | 2024 | 39713609 | PubTator, text mining | PubMed |
| Potential and emerging therapeutics for HHT. | Hematology Am Soc Hematol Educ Program | 2024 | 39644056 | PubTator, text mining | PubMed |
| Hereditary hemorrhagic telangiectasia: A pediatric-focused review. | Semin Pediatr Neurol | 2024 | 39622607 | PubTator, text mining | PubMed |
| Pulmonary vascular manifestations of hereditary haemorrhagic telangiectasia. | Pulm Circ | 2024 | 39588537 | PubTator, text mining | PubMed |
| Discovery of highly potent and ALK2/ALK1 selective kinase inhibitors using DNA-encoded chemistry technology. | Proc Natl Acad Sci U S A | 2024 | 39541346 | PubTator, text mining | PubMed |
| CDK6-mediated endothelial cell cycle acceleration drives arteriovenous malformations in hereditary hemorrhagic telangiectasia. | Nat Cardiovasc Res | 2024 | 39487364 | PubTator, text mining | PubMed |
| ALK1 Signaling in Human Cardiac Progenitor Cells Promotes a Pro-angiogenic Secretome. | J Cell Signal | 2024 | 39430425 | PubTator, text mining | PubMed |
| Respiratory Tract Infection Leading to the Diagnosis of Hereditary Hemorrhagic Telangiectasia in a Puerto Rican Patient: A Case Report. | Cureus | 2024 | 39314615 | PubTator, text mining | PubMed |
| Targeting Fascin1 maintains chondrocytes phenotype and attenuates osteoarthritis development. | Bone Res | 2024 | 39231936 | PubTator, text mining | PubMed |
| Abstracts Presented at the 2024 WIN Symposium in Partnership with Burjeel Holdings: March 1-2, 2024, Abu Dhabi, United Arab Emirates. | J Immunother Precis Oncol | 2024 | 39219997 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/94/papers?page=8